REFERENCES
1. Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-55.
2. Chace DH, Spitzer AR. Altered metabolism and newborn screening using tandem mass spectrometry: lessons learned from the bench to bedside. Curr Pharm Biotechnol 2011;12:965-75.
3. Watson MS, Lloyd-Puryear MA, Howell RR. The progress and future of US newborn screening. Int J Neonatal Screen 2022;8:41.
4. van Karnebeek CD, Tiebout SA, Niermeijer J, et al. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatr Neurol 2016;59:6-12.
5. McCombie WR, McPherson JD, Mardis ER. Next-generation sequencing technologies. Cold Spring Harb Perspect Med 2019;9:a036798.
6. Dimmock D, Caylor S, Waldman B, et al. Project baby bear: rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet 2021;108:1231-8.
7. Krantz ID, Medne L, Weatherly JM, et al; NICUSeq Study Group. Effect of whole-genome sequencing on the clinical management of acutely Ill infants with suspected genetic disease: a randomized clinical trial. JAMA Pediatr 2021;175:1218-26.
8. Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically Ill infants. NPJ Genom Med 2018;3:6.
9. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med 2018;3:10.
10. Mestek-Boukhibar L, Clement E, Jones WD, et al. Rapid paediatric sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet 2018;55:721-8.
11. van Diemen CC, Kerstjens-Frederikse WS, Bergman KA, et al. Rapid targeted genomics in critically Ill newborns. Pediatrics 2017;140:e20162854.
12. Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med 2015;3:377-87.
13. Ceyhan-Birsoy O, Murry JB, Machini K, et al. BabySeq Project Team. Interpretation of genomic sequencing results in healthy and Ill newborns: results from the BabySeq project. Am J Hum Genet 2019;104:76-93.
14. Dimmock DP, Clark MM, Gaughran M, et al. RCIGM Investigators. An RCT of rapid genomic sequencing among seriously Ill infants results in high clinical utility, changes in management, and low perceived harm. Am J Hum Genet 2020;107:942-52.
15. Bick D, Bick SL, Dimmock DP, Fowler TA, Caulfield MJ, Scott RH. An online compendium of treatable genetic disorders. Am J Med Genet C Semin Med Genet 2021;187:48-54.
16. Owen MJ, Lefebvre S, Hansen C, et al. An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases. Nat Commun 2022;13:4057.
17. GUARDIAN Study. Available from: https://guardian-study.org [Last accessed on 27 Sep 2023].
18. BeginNGS. Available from: https://radygenomics.org/begin-ngs-newborn-sequencing/ [Last accessed on Last accessed on 27 Sep 2023].
19. Early Check. Available from: https://earlycheck.org/news-and-outreach/newsroom/ [Last accessed on 27 Sep 2023].
20. Screen4Care (European Union). Available from: https://screen4care.eu/ [Last accessed on 27 Sep 2023].
21. Pichini A, Ahmed A, Patch C, et al. Developing a national newborn genomes program: an approach driven by ethics, engagement and co-design. Front Genet 2022;13:866168.
22. The UK Newborn Genomes Programme. Available from: https://www.genomicsengland.co.uk/initiatives/newborns [Last accessed on 27 Sep 2023].
23. Baby Detect. Available from: https://babydetect.com [Last accessed on 27 Sep 2023].
25. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968. Available from: https://policycommons.net/artifacts/537214/principles-and-practice-of-screening-for-disease-j/1513770/ [Last accessed on 27 Sep 2023].
26. Key principles for newborn screening (2021). Available from: https://www.eurordis.org/publications/key-principles-for-newborn-screening/ [Last accessed on 27 Sep 2023].
27. Balciuniene J, Liu R, Bean L, et al. At-risk genomic findings for pediatric-onset disorders from genome sequencing vs medically actionable gene panel in proactive screening of newborns and children. JAMA Netw Open 2023;6:e2326445.
28. Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.
29. Oliver GR, Hart SN, Klee EW. Bioinformatics for clinical next generation sequencing. Clin Chem 2015;61:124-35.
30. Owen MJ, Niemi AK, Dimmock DP, et al. Rapid sequencing-based diagnosis of thiamine metabolism dysfunction syndrome. N Engl J Med 2021;384:2159-61.
31. Austin-Tse CA, Jobanputra V, Perry DL, et al. Medical Genome Initiative*. Best practices for the interpretation and reporting of clinical whole genome sequencing. NPJ Genom Med 2022;7:27.
32. Souche E, Beltran S, Brosens E, et al. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur J Hum Genet 2022;30:1017-21.
33. Nurchis MC, Riccardi MT, Radio FC, et al. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: systematic review and meta-analysis of cost-effectiveness evidence. Health Policy 2022;126:337-45.
34. NIH National Human Genome Research Institute. DNA Sequencing Costs: data. Available from: https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data [Last accessed on 27 Sep 2023].
35. Incerti D, Xu XM, Chou JW, Gonzaludo N, Belmont JW, Schroeder BE. Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genet Med 2022;24:109-18.
36. Implications of whole genome sequencing for newborn screening-a public dialogue. Available from: https://files.genomicsengland.co.uk/documents/public-dialogue-wgs-for-nbs-final-report.pdf [Last accessed on 27 Sep 2023].
